Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia
N Novak, L Tordesillas, B Cabanillas - International reviews of …, 2022 - Taylor & Francis
Vaccines for the prevention of coronavirus disease 2019 (COVID-19) started to be
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …
Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia.
N Novak, L Tordesillas, B Cabanillas - International Reviews of …, 2021 - europepmc.org
Vaccines for the prevention of coronavirus disease 2019 (COVID-19) started to be
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …
[PDF][PDF] Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia
N Novak, L Tordesillas, B Cabanillas - Int Rev Immunol, 2021 - mcl-corp.jp
抄録 2019 年の新型コロナウイルス感染症 (COVID-19) の予防を目的としたワクチンの開発は,
COVID-19 のパンデミック (世界的大流行) が始まってから始まった. これまでに欧州医薬品庁 …
COVID-19 のパンデミック (世界的大流行) が始まってから始まった. これまでに欧州医薬品庁 …
[HTML][HTML] Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia
N Novak, L Tordesillas, B Cabanillas - International Reviews of …, 2021 - ncbi.nlm.nih.gov
Vaccines for the prevention of coronavirus disease 2019 (COVID-19) started to be
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …
Adverse rare events to vaccines for COVID-19: from hypersensitivity reactions to thrombosis and thrombocytopenia.
N Novak, L Tordesillas, B Cabanillas - 2022 - cabidigitallibrary.org
Vaccines for the prevention of coronavirus disease 2019 (COVID-19) started to be
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …
[引用][C] Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia
N Novak, L Tordesillas, B Cabanillas - International Reviews of …, 2021 - cir.nii.ac.jp
Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis
and thrombocytopenia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
and thrombocytopenia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia
N Novak, L Tordesillas… - International reviews of …, 2022 - pubmed.ncbi.nlm.nih.gov
Vaccines for the prevention of coronavirus disease 2019 (COVID-19) started to be
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …
developed since the initiation of the COVID-19 pandemic. Up to now, four vaccines have …